Dr Charlotte Tye
Senior Lecturer
Research interests
- Neuroscience
Contact details
Biography
Dr Charlotte Tye is a Senior Lecturer. Charlotte completed a BSc in Experimental Psychology at the University of Bristol, and a MSc and PhD at the Social, Genetic and Developmental Psychiatry Centre, King’s College London.
Charlotte’s research focuses on characterising development in young children with rare genetic conditions and epilepsy, and identifying infant precursors of later emerging neurodevelopmental conditions, such as autism and ADHD. She uses EEG, eye-tracking, cognitive and behavioural measures within longitudinal studies.
Research Interests:
Autism
ADHD
Neurocognitive development (eye-tracking, EEG)
Epilepsy
Rare genetic syndromes
Expertise and Public Engagement:
Charlotte works closely with several charities who support her research, to provide accessible summaries and presentations of research findings for the community, including the Tuberous Sclerosis Association, Epilepsy Research UK, Autistica, Rare Revolution Magazine and Genetic Alliance UK. She sits on the Early Career Researcher Committee of the Tuberous Sclerosis Association, and co-chairs the Adolescent Advisory Group as part of the NIHR Maudsley Biomedical Research Centre.
Research
King's Epilepsy Research Collective (KERC)
The King’s Epilepsy Research Collective (KERC) provides a platform for researchers from all of King’s faculties to meet and discuss research and to support collaborative activities.
News
£1.1 million NIHR/MRC node established to study mTOR pathway rare diseases
Professor Joseph Bateman, Professor Deb Pal and Dr Laura Mantoan-Ritter received the funding to establish the mTOR Pathway Diseases node as part of the new...
Research
King's Epilepsy Research Collective (KERC)
The King’s Epilepsy Research Collective (KERC) provides a platform for researchers from all of King’s faculties to meet and discuss research and to support collaborative activities.
News
£1.1 million NIHR/MRC node established to study mTOR pathway rare diseases
Professor Joseph Bateman, Professor Deb Pal and Dr Laura Mantoan-Ritter received the funding to establish the mTOR Pathway Diseases node as part of the new...